AstraZeneca PLC AZN shares slid 1.69% to £116.08 Friday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index UKX falling 0.63% to 8,646.79.

AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just ...

Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” fourth quarter 2024 ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

AstraZeneca boosts cancer therapies push with ... a positive outcome in the development of the therapy key to the company's pipeline. February 24, 2025 FTSE 100 flat as investors await speeches ...

Tallying up a wide range of investments, AstraZeneca said it is pumping $2.5 billion into Beijing. The figure includes ...

Independent Advisor Alliance increased its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 13.0% in the fourth ...

BEIJING] AstraZeneca will invest US$2.5 billion in a new research centre in Beijing, in a major show of commitment to China ...

The Cambridge, England-based pharmaceutical company said it will invest USD2.5 billion in China's capital to establish its sixth global strategic R&D centre alongside other major research and ...

Syneron Bio has partnered with AstraZeneca to develop potential first-in-class macrocyclic peptides for the treatment of ...

AstraZeneca (AZN) announced an investment of $2.5B in Beijing to establish its sixth global strategic R&D center together with major ...

AstraZeneca (AZN) stock in focus as the company invests $2.5B in Beijing for a new R&D center, strengthening its footprint in ...